Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Imaging Chemicals Market Poised To Hit $38.72 Billion By 2030 With A 6.7% CAGR#_x000D_
The imaging chemicals market has experienced substantial expansion in recent years. This market is projected to expand from $27.93 billion in 2025 to $29.93 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Historically, this growth can be ascribed to factors such as the growth of packaging and label printing, the expansion of medical imaging diagnostics, the rising use of chemical developers, established demand in textile printing, and the availability of conventional imaging chemicals._x000D_
_x000D_
The imaging chemicals market size is anticipated to demonstrate significant expansion in the coming years, projected to reach $38.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. The expected growth during this forecast period is attributable to the increasing adoption of digital printing technologies, a rising demand for sustainable inks and toners, the expansion of healthcare imaging applications, growing investments in specialty chemical innovation, and an increasing regulatory focus on low-VOC formulations. Prominent trends throughout the forecast period involve an increasing shift toward digital imaging chemicals, a rising demand for high-resolution printing inks, expanding use in medical diagnostic imaging, the development of eco-friendly imaging formulations, and enhanced performance of specialty toners._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Imaging Chemicals Market Growth Factors: What’s Supporting Expansion?#_x000D_
The increasing occurrence of chronic diseases is expected to propel the expansion of the imaging chemicals market in the upcoming period. These long-term medical conditions, referred to as non-communicable diseases (NCDs), are characterized by their enduring nature. Imaging chemicals are essential for the diagnosis, monitoring, and management of chronic diseases, acting as contrast agents or tracers in diverse imaging modalities. This allows healthcare professionals to visualize internal bodily structures, detect irregularities, and assess the progression of long-term conditions. For instance, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government health statistics agency, in July 2024, chronic conditions contributed to 78% of the fatal burden, a rise from preceding years. Hence, the rising incidence of chronic diseases is a significant driver for the imaging chemicals market._x000D_
_x000D_
#Imaging Chemicals Market Segment Landscape And Growth Outlook#_x000D_
The imaging chemicals market covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Imaging Agents And Toners, Printing Inks, Image Developers _x000D_
2) By Application: Medical Diagnostics, Packaging And Printing, Textile Processing, Mining, Other Applications_x000D_
3) By Form: Liquid, Powder_x000D_
_x000D_
Subsegments:_x000D_
1) By Imaging Agents And Toners: Liquid Toners, Powder Toners, Imaging Agents For Medical Imaging _x000D_
2) By Printing Inks: Solvent-Based Inks, Water-Based Inks, UV-Curable Inks, Eco-Friendly Inks _x000D_
3) By Image Developers: Photographic Developers, Digital Imaging Developers, Chemical Developers For X-Ray Imaging_x000D_
_x000D_
#Imaging Chemicals Market Industry Trends: What’s Reshaping Demand?#_x000D_
Major companies in the imaging chemicals market are concentrating on developing innovative solutions, such as next-generation gadolinium-based contrast agents (GBCAs), to address the increasing demand for safer, more efficient, and higher-resolution diagnostic imaging. Technologically advanced contrast agents provide enhanced relaxivity and necessitate lower dosing compared to traditional formulations, thereby mitigating safety concerns associated with gadolinium exposure while enabling clearer and more precise MRI visualization. For instance, in February 2023, Guerbet Group, a France-based pharmaceutical and medical imaging company, introduced the Elucirem (gadopiclenol) injection. This latest generation GBCA from Guerbet offers the greatest relaxivity within the magnetic resonance imaging (MRI) category and is recommended for use in both adults and children aged 2 years and older. Elucirem requires half the gadolinium dosage of traditional non-specific GBCAs, effectively easing practitioners’ worries about gadolinium exposure. The Elucirem (gadopiclenol) injection is capable of detecting and visualizing lesions with aberrant vascularity in the central nervous system (brain, spine, and related tissues) and throughout the body (head and neck, chest, stomach, pelvis, and musculoskeletal system)._x000D_
_x000D_
#Imaging Chemicals Market Competitive Landscape: Who Leads The Industry?#_x000D_
Major companies operating in the imaging chemicals market are Eastman Kodak Company, Agfa-Gevaert NV, Altana AG, BASF SE, Clariant Chemical Company, DIC Corporation, Dow Chemical Company, Flint Group S.A., FUJIFILM Holdings Corporation, Hubergroup Deutschland GmbH, Kao Corporation, Kodak Alaris Inc., Qingdao Scienoc Chemical Co., Sakata Inx Corp., Siegwerk Druckfarben AG & Co. KGaA, T&K TOKA Corporation, Toyo Ink SC Holdings Co. Ltd., Wikoff Color Corporation, Evonik Industries AG, Merck Co. & KGaA _x000D_
_x000D_
#View The Full Imaging Chemicals Market Report:#_x000D_
_x000D_
#Imaging Chemicals Market Regional Analysis: Which Geography Leads On Revenue?#_x000D_
Asia-Pacific was the largest region in the imaging chemicals market in 2025. The regions covered in the imaging chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
